Novynette (Desogestrel, Ethinylestradiol)

Desogestrel, the active ingredient in Novynette, is a progestin presented as a combined oral contraceptive for oral use. It prevents ovulation and stabilises the uterine lining to provide reliable birth control for women of reproductive age.

GNH USA supplies Novynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novynette is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle. - Contraception: Provides effective prevention of pregnancy when taken as directed. - Menstrual cycle regulation: Helps to achieve more predictable bleeding patterns. - Acne improvement: Reduces androgen‑related skin lesions in some users.

Novynette may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that usually resolves with continued use. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Weight gain: slight increase in body weight, often fluid‑related. - Mood changes: irritability or emotional lability. - Spotting between periods: light vaginal bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Severe hypertension: sudden, marked increase in blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Allergic reaction: rash, itching, swelling or anaphylaxis.

Before prescribing Novynette, clinicians should assess individual risk factors and counsel patients on safe use. - Smoking status: avoid use in women over 35 who smoke. - Cardiovascular history: assess for hypertension, clotting disorders or heart disease. - Migraine history: caution in patients with migraine with aura. - Liver function: evaluate hepatic impairment before initiation. - Pregnancy and lactation: contraindicated during pregnancy; advise breastfeeding women of potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Novynette can interact with several medicines that affect its metabolism or clotting risk.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): increase estrogen levels and thrombosis risk. - Antiretroviral protease inhibitors (ritonavir): elevate plasma concentrations of both hormones. - Strong CYP3A4 inducers (rifampicin, carbamazepine): reduce hormonal efficacy, increasing pregnancy risk.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may alter bleeding patterns. - Anticonvulsants (phenytoin, phenobarbital): modestly decrease contraceptive effectiveness. - Herbal supplements (St. John’s wort): may reduce hormone levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can increase blood pressure. - Antibiotics (tetracycline, metronidazole): generally minimal effect but monitor for breakthrough bleeding.